pharmaceuticals-and-healthcare

Global Prostate Cancer Diagnostics Market Research Report 2017


Published On : Apr 2017

Category : Cancer Diagnostics

No. of Pages : 121 pages

  • $2900
  • $5800

Please click below to avail discount on this report

In the last several years, global market of Prostate Cancer Diagnostics developed rapidly, with an average growth rate of 7.1%. In 2016, global revenue of Prostate Cancer Diagnostics is nearly 11 billion USD.

This report studies Prostate Cancer Diagnostics in Global market, especially in North America, Europe, Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market Segment by Regions, this report splits Global into several key Regions, with revenue, and market share and growth rate of Prostate Cancer Diagnostics in these regions, from 2012 to 2022 (forecast), like
North America
Europe
Japan
Asia (Ex. Japan)
Other

Split by Product Types, with revenue and market share and growth rate of each type, can be divided into
Tumor Biomarker Tests
Imaging
Biopsy
Other

Split by Ages, this report focuses on sales, market share and growth rate of Prostate Cancer Diagnostics in each ages, can be divided into
< 55
55-75
> 75

Cancer diagnostics involves various methods and techniques for diagnosing cancer in several stages. Many of the cancer types are primarily recognized either through screening or through the appearance of early signs and symptoms. However, these do not lead to a conclusive diagnosis which needs a pathologist to examine a tissue sample. Patients suspected with cancer go through several medical tests such as endoscopy, CT scans, X-rays, and blood tests. For instance, oncology is part of medicine that is relate to the diagnosis, treatment, and prevention of cancer. The growing number of private diagnostic centers is anticipated to bode well for the growth of the cancer diagnostics industry.

The research report specifies various aspects of the Global prostate cancer diagnostics market research report 2017 market with transparent and clear picture of the current and future conditions of the market along with germane information regarding the market. It also puts focus on the developments and elements at play that are expected to impact the growth of the Global prostate cancer diagnostics market research report 2017 market in the long run. The forecast period covered in the report has been thought of microscopically and the researchers have further penetrated into industrial and production chain of the concerned market. This is also expected to help in broadcasting accurate statistics and data on multiple aspects concerning to the Global prostate cancer diagnostics market research report 2017 market. Such factors might include government policies in the global and regional strata, production and product flow structure, manufacturing capacity of the production unit, products sold, and revenue earned along with the profit margins being met.

The market study further provides a comprehensive examination of the regions mentioned in the report for the market for Global prostate cancer diagnostics market research report 2017. For every mentioned region, the report articulates the progress of the market so far and the upcoming growth has also been mapped in the report. The market research report will also present an edifying overview of the competitive landscape of the Global prostate cancer diagnostics market research report 2017 market with a compilation of inventions, activities, facts, figures, product portfolio, and strategies. Special focus has been put on occurring mergers and acquisitions along with upcoming agreements and developments of the influential market players. 

Table of Contents

1 Prostate Cancer Diagnostics Market Overview1
1.1 Product Overview and Scope of Prostate Cancer Diagnostics1
1.2 Prostate Cancer Diagnostics Segment by Types2
1.2.1 Global Revenue Market Share of Prostate Cancer Diagnostics by Types in 20162
1.2.2 Tumor Biomarker Tests3
1.2.3 Imaging3
1.2.4 Biopsy3
1.2.5 Other4
1.3 Prostate Cancer Diagnostics Segment by Ages5
1.4 Prostate Cancer Diagnostics Market by Regions7
1.4.1 North America Status and Prospect (2012-2022)7
1.4.2 Japan Status and Prospect (2012-2022)8
1.4.3 Europe Status and Prospect (2012-2022)8
1.4.4 Asia (Ex. Japan) Status and Prospect (2012-2022)9
1.4.5 Other Status and Prospect (2012-2022)9
1.5 Global Market Size (Value) of Prostate Cancer Diagnostics (2012-2022)10
2 Global Prostate Cancer Diagnostics Market Competition by Manufacturers11
2.1 Global Prostate Cancer Diagnostics Revenue and Share by Manufacturers (2016 and 2017)11
2.2 Global Prostate Cancer Diagnostics Gross and Share by Manufacturers (2016 and 2017)13
2.3 Global Prostate Cancer Diagnostics Average Gross Margin by Manufacturers (2016 and 2017)16
2.4 Manufacturers Prostate Cancer Diagnostics Headquarters and Established Date18
2.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends20
2.5.1 Prostate Cancer Diagnostics Market Concentration Rate20
2.5.2 Prostate Cancer Diagnostics Market Share of Top 3 and Top 5 Manufacturers21
2.5.3 Mergers & Acquisitions, Expansion22
3 Global Prostate Cancer Diagnostics Gross, Revenue (Value) by Regions (2012-2017)23
3.1 Global Prostate Cancer Diagnostics Revenue (Value) and Market Share by Regions (2012-2017)23
3.2 Global Prostate Cancer Diagnostics Gross and Market Share by Regions (2012-2017)25
3.3 Global Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.4 North America Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.5 Europe Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
3.6 Japan Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
3.7 Asia (Ex. Japan) Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
3.8 Other Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
4 Global Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)29
4.1 Global Prostate Cancer Diagnostics Consumption Value by Regions (2012-2017)29
4.2 North America Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
4.3 Europe Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
4.4 Japan Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32
4.5 Asia (Ex. Japan) Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32
5 Global Prostate Cancer Diagnostics Gross, Revenue (Value), Gross Margin Trend by Types33
5.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Types (2012-2017)33
5.2 Global Prostate Cancer Diagnostics Gross and Market Share by Types (2012-2017)35
5.3 Global Prostate Cancer Diagnostics Gross Margin by Type (2012-2017)36
5.4 Global Prostate Cancer Diagnostics Gross Growth by Type (2012-2017)37
6 Global Prostate Cancer Diagnostics Market Analysis by Ages38
6.1 Global Prostate Cancer Diagnostics Consumption Value and Market Share by Ages (2012-2017)38
6.2 Global Prostate Cancer Diagnostics Consumption Value Growth Rate by Ages (2012-2017)40
6.3 Market Drivers and Opportunities41
6.3.1 Potential Applications41
6.3.2 Emerging Markets/Countries41
7 Major Manufacturers Analysis of Prostate Cancer Diagnostics42
7.1 Genomic Health42
7.1.1 Company Profile42
7.1.2 Product Information42
7.1.3 Revenue, Gross and Market Share43
7.2 Abbott44
7.2.1 Company Profile44
7.2.2 Product Information46
7.2.3 Revenue, Gross and Market Share46
7.3 OPKO46
7.3.1 Company Profile46
7.3.2 Product Information47
7.3.3 Revenue, Gross and Market Share48
7.4 Siemens Healthcare49
7.4.1 Company Profile49
7.4.2 Product Information50
7.4.3 Revenue, Gross and Market Share50
7.5 DiaSorin51
7.5.1 Company Profile51
7.5.2 Product Information52
7.5.3 Revenue, Gross and Market Share52
7.6 BioMeriux53
7.6.1 Company Profile53
7.6.2 Product Information53
7.6.3 Revenue, Gross and Market Share54
7.7 Roche55
7.7.1 Company Profile55
7.7.2 Product Information56
7.7.3 Revenue, Gross and Market Share56
7.8 MDx Health56
7.8.1 Company Profile56
7.8.2 Product Information57
7.8.3 Revenue, Gross and Market Share58
7.9 Beckman Coulter59
7.9.1 Company Profile59
7.9.2 Product Information60
7.9.3 Revenue, Gross and Market Share60
7.10 Myriad Genetics61
7.10.1 Company Profile61
7.10.2 Product Information62
7.10.3 Revenue, Gross and Market Share62
7.11 Ambry Genetics63
7.11.1 Company Profile63
7.11.2 Product Information64
7.11.3 Revenue, Gross and Market Share64
8 Prostate Cancer Diagnostics Manufacturing Cost Analysis65
8.1 Prostate Cancer Treatment Key Equipment Supplier65
8.2 Proportion of Manufacturing Cost Structure65
8.2.1 Raw Materials66
8.2.2 Labor Cost Analysis66
8.2.3 Other Costs Analysis71
8.3 Diagnostics Process Analysis of Prostate Cancer76
8.3.1 Tumor Biomarker Tests76
8.3.2 PSA Test Process77
8.3.3 Imaging79
8.3.4 Biopsy80
9 Industrial Chain, Sourcing Strategy and Downstream Buyers81
9.1 Prostate Cancer Diagnostics Industrial Chain Analysis81
9.2 Upstream Raw Materials Sourcing82
9.3 Downstream Buyers82
10 Marketing Strategy Analysis, Distributors/Traders85
10.1 Marketing Channel85
10.1.1 Direct Marketing85
10.1.2 Indirect Marketing85
10.1.3 Marketing Channel Development Trend85
10.2 Market Positioning86
10.2.1 Pricing Strategy86
10.2.2 Brand Strategy86
10.2.3 Target Client86
10.3 Distributors/Traders List86
11 Market Effect Factors Analysis88
11.1 Technology Progress/Risk88
11.1.1 Substitutes Threat88
11.1.2 Technology Progress in Related Industry88
11.2 Consumer Needs/Customer Preference Change88
11.3 Economic/Political Environmental Change88
12 Global Prostate Cancer Diagnostics Market Forecast (2017-2022)97
12.1 Global Prostate Cancer Diagnostics Gross, Revenue Forecast (2017-2022)97
12.2 Global Prostate Cancer Diagnostics Revenue, Consumption Value Forecast by Regions (2017-2022)98
12.3 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2017-2022)99
12.4 Global Prostate Cancer Diagnostics Consumption Value Forecast by Ages (2017-2022)99
12.5 Prostate Cancer Diagnostics Gross Margin Forecast (2017-2022) by Regions100
13 Research Findings and Conclusion101
14 Appendix102
14.1 Methodology/Research Approach102
14.1.1 Research Programs/Design102
14.1.2 Market Size Estimation103
14.1.3 Market Breakdown and Data Triangulation104
14.2 Data Source105
14.2.1 Secondary Sources105
14.2.2 Primary Sources106
14.3 Disclaimer107
14.4 Author List109


List of Tables and Figures

Figure Picture of Prostate Cancer Diagnostics1
Figure Global Revenue Market Share of Prostate Cancer Diagnostics by Types in 20162
Table Classification of Prostate Cancer Diagnostics2
Figure Product Picture of Imaging3
Figure Product Picture of Biopsy4
Figure Product Picture of Other5
Figure Prostate Cancer Diagnostics Consumption Value Market Share by Ages in 20165
Figure Ages of Prostate Cancer Diagnostics6
Figure North America Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)7
Figure Japan Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)8
Figure Europe Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)8
Figure Asia (Ex. Japan) Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)9
Figure Other Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)9
Figure Global Prostate Cancer Diagnostics Revenue (M USD) and Growth Rate (2012-2022)10
Table Global Prostate Cancer Diagnostics Revenue (M USD) by Manufacturers (2016 and 2017)11
Table Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2016 and 2017)11
Figure 2016 Global Prostate Cancer Diagnostics Revenue Share by Manufacturers12
Figure 2017 Global Prostate Cancer Diagnostics Revenue Share by Manufacturers13
Table Global Prostate Cancer Diagnostics Gross (M USD) of Key Manufacturers (2016 and 2017)13
Table Global Prostate Cancer Diagnostics Gross Share by Manufacturers (2016 and 2017)14
Figure 2016 Prostate Cancer Diagnostics Gross Share by Manufacturers15
Figure 2017 Prostate Cancer Diagnostics Gross Share by Manufacturers15
Table Global Market Prostate Cancer Diagnostics Average Gross Margin of Key Manufacturers (2016 and 2017)16
Figure Global Market Prostate Cancer Diagnostics Average Gross Margin of Key Manufacturers in 201617
Figure Global Market Prostate Cancer Diagnostics Average Gross Margin of Key Manufacturers in 201718
Table Manufacturers Prostate Cancer Diagnostics Headquarters18
Table Manufacturers Prostate Cancer Diagnostics Established Date19
Figure Prostate Cancer Diagnostics Revenue Market Concentration Rate in 201620
Figure Prostate Cancer Diagnostics Revenue Market Share of Top 3 Manufacturers in 201621
Figure Prostate Cancer Diagnostics Revenue Market Share of Top 5 Manufacturers in 201621
Table Global Prostate Cancer Diagnostics Revenue (M USD) by Regions (2012-2017)23
Table Global Prostate Cancer Diagnostics Revenue Market Share by Regions (2012-2017)23
Figure 2012 Global Prostate Cancer Diagnostics Revenue Market Share by Regions24
Table 2016 Global Prostate Cancer Diagnostics Revenue Market Share by Regions24
Table Global Prostate Cancer Diagnostics Gross (M USD) by Regions (2012-2017)25
Figure Global Prostate Cancer Diagnostics Gross and Market Share by Regions (2012-2017)25
Figure 2012 Global Prostate Cancer Diagnostics Gross Market Share by Regions26
Figure 2016 Global Prostate Cancer Diagnostics Gross Market Share by Regions26
Table Global Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
Table North America Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
Table Europe Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)27
Table Japan Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
Table Asia (Ex. Japan) Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
Table Other Prostate Cancer Diagnostics Revenue, Gross and Gross Margin (2012-2017)28
Table Global Prostate Cancer Diagnostics Consumption Value (M USD) Market by Regions (2012-2017)29
Table Global Prostate Cancer Diagnostics Consumption Value Market Share by Regions (2012-2017)29
Figure Global Prostate Cancer Diagnostics Consumption Value Market Share by Regions (2012-2017)30
Figure 2016 Global Prostate Cancer Diagnostics Consumption Value Market Share by Regions30
Table North America Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
Table Europe Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)31
Table Japan Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32
Table Asia (Ex. Japan) Prostate Cancer Diagnostics Supply, Consumption Value, Export, Import by Regions (2012-2017)32
Table Global Prostate Cancer Diagnostics Revenue (M USD) by Types (2012-2017)33
Table Global Prostate Cancer Diagnostics Revenue Share by Types (2012-2017)33
Figure Gross Revenue Share of Prostate Cancer Diagnostics by Types (2012-2017)34
Figure 2016 Revenue Market Share of Prostate Cancer Diagnostics by Types34
Table Global Prostate Cancer Diagnostics Gross (M USD) by Types (2012-2017)35
Table Global Prostate Cancer Diagnostics Gross Share by Types (2012-2017)35
Figure Gross Market Share of Prostate Cancer Diagnostics by Types (2012-2017)35
Figure 2016 Gross Market Share of Prostate Cancer Diagnostics by Types36
Table Global Prostate Cancer Diagnostics Gross Margin by Types (2012-2017)36
Figure Global Prostate Cancer Diagnostics Gross Growth by Type (2012-2017)37
Table Global Prostate Cancer Diagnostics Consumption Value (M USD) by Ages (2012-2017)38
Table Global Prostate Cancer Diagnostics Consumption Value Market Share by Ages (2012-2017)38
Figure Global Prostate Cancer Diagnostics Consumption Value Market Share by Ages in 201239
Figure Global Prostate Cancer Diagnostics Consumption Value Market Share by Ages in 201639
Table Global Prostate Cancer Diagnostics Consumption Value Growth Rate by Ages (2012-2017)40
Figure Global Prostate Cancer Diagnostics Consumption Value Growth Rate by Ages (2012-2017)40
Table Countries of the Top 15 Highest Incidence of Prostate Cancer in 201241
Table Genomic Health Information List42
Figure Prostate Cancer Journey43
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Genomic Health (2016 and 2017)43
Table Abbott Information List44
Figure Prostate Cancer Diagnostics Picture of Abbott46
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Abbott (2016 and 2017)46
Table OPKO Information List47
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of OPKO (2016 and 2017)48
Table Siemens Healthcare Information List49
Figure Prostate Cancer Diagnostics Picture of Siemens Healthcare50
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Siemens Healthcare (2016 and 2017)50
Table DiaSorin Information List51
Figure Prostate Cancer Diagnostics Picture of DiaSorin52
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of DiaSorin (2016 and 2017)52
Table BioMeriux Information List53
Figure Precision and reliability54
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of BioMeriux (2016 and 2017)54
Table Roche Information List55
Figure Prostate Cancer Diagnostics Specifications of Roche56
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Roche (2016 and 2017)56
Table MDx Health Information List57
Figure Prostate Cancer Diagnostics Picture of MDx Health58
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of MDx Health (2016 and 2017)58
Table Beckman Coulter Information List59
Figure Prostate Cancer Diagnostics Picture and Specifications of Beckman Coulter60
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Beckman Coulter (2016 and 2017)60
Table Myriad Genetics Information List61
Figure Prostate Cancer Diagnostics Picture and Specifications of Myriad Genetics62
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Myriad Genetics (2016 and 2017)62
Table Ambry Genetics Information List63
Table Prostate Cancer Diagnostics Specifications of Ambry Genetics64
Table Prostate Cancer Diagnostics Revenue (M USD), Cost (M USD), Gross (M UD) and Gross Margin of Ambry Genetics (2016 and 2017)64
Table Key Treatment Suppliers of Diagnostics65
Table Manufacturing Cost Structure of Prostate Cancer Diagnostics65
Figure USA Labor Cost Analysis 2012-201666
Figure Cost of Employing a Factory Worker68
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe69
Figure Monthly Minimum Wages in Asia 201670
Figure China Labor Costs 2013-201670
Table Average Price of Electricity to Ultimate Customers 2007-201671
Figure Electricity Prices for Household Consumers in 201672
Figure Summary of the Driving Assumptions74
Figure Industrial Electric Rates 2016 (PER KWH)74
Figure Manufacturing Process Analysis of PSA Test78
Figure Prostate Cancer Diagnostics Industrial Chain Analysis81
Table Major Buyers of Prostate Cancer Diagnostics82
Table Distributors/Traders List86
Figure Global GDP Growth Rate for 201589
Figure US GDP 2006-2016 (Billion USD)90
Figure US CPI Change 2016-201790
Figure EU GDP 2006-2016 (Billion USD)91
Figure EU CPI Change 2012-201691
Figure Germany GDP 2006-2016 (Billion USD)92
Figure Germany CPI Change 2016-201792
Figure UK GDP 2006-2016 (Billion USD)93
Figure UK CPI Change 2016-201793
Figure Italy GDP 2006-2016 (Billion USD)94
Figure Italy CPI Change 2016-201794
Figure Japan GDP 2006-2016 (Billion USD)95
Figure Japan CPI Change 2012-201695
Figure China GDP 2006-2016 (Billion USD)96
Figure China CPI Change 2016-201796
Figure Global Prostate Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)97
Figure Global Prostate Cancer Diagnostics Gross and Growth Rate Forecast (2017-2022)98
Table Global Prostate Cancer Diagnostics Revenue (M USD) Forecast by Regions (2017-2022)98
Table Global Prostate Cancer Diagnostics Consumption Value (M USD) Forecast by Regions (2017-2022)99
Table Global Prostate Cancer Diagnostics Revenue (M USD) Forecast by Type (2017-2022)99
Table Global Prostate Cancer Diagnostics Consumption Value (M USD) Forecast by Ages (2017-2022)99
Table Prostate Cancer Diagnostics Gross Margin Forecast (2017-2022) by Regions100
Table Research Programs/Design for This Report102
Figure Bottom-up and Top-down Approaches for This Report104
Figure Data Triangulation105
Table Key Data Information from Secondary Sources106
Table Key Data Information from Primary Sources107

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top